<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01908790</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00075160</org_study_id>
    <nct_id>NCT01908790</nct_id>
  </id_info>
  <brief_title>Correlation of Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter and Central Venous Catheter</brief_title>
  <official_title>Correlation of Venous Oxygen Saturation Measurements by Non-invasive Mespere Venous Oximeter vs Venous Oxygen Saturation From Blood Samples From the Jugular Vein vs Central Venous Oxygen Saturation vs Mixed Venous Oxygen Saturation, Measured by a CO-Oximeter.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mespere Lifesciences Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mespere Lifesciences Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish the accuracy of the non-invasive Mespere Oximeter&#xD;
      that estimates venous oxygen saturation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The conventional pulse oximeter has been a standard in clinical care for non-invasive&#xD;
      hemodynamic monitoring, which only measures arterial blood oxygenation. The clinical&#xD;
      application of venous oximetry is numerous, including severe sepsis and septic shock, severe&#xD;
      trauma and hemorrhagic shock, and heart failure and cardiac arrest.&#xD;
&#xD;
      The existing method for venous blood oxygenation monitored is either through an invasive&#xD;
      fiber optic catheter, or intermittently by blood sampling and CO-Oximetry. However,&#xD;
      catheterization can be costly and can include inherent risks. Therefore, due to the inherent&#xD;
      risks of catheterization, venous oximetry is limited only to critically ill patients.&#xD;
&#xD;
      By non-invasively monitoring venous blood oxygenation, the Mespere Oximeter provides more&#xD;
      complete information on patient hemodynamics.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mespere Oximeter venous oxygen saturation accuracy compared to CO-Oximeter</measure>
    <time_frame>0-10 minutes</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Validation of Oximeter System</condition>
  <arm_group>
    <arm_group_label>Heart Failure Patients</arm_group_label>
    <description>Acute and chronic heart failure patients already receiving right heart catheterization (RHC) as part of their usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mespere Venous Oximeter</intervention_name>
    <description>The Mespere VA Oximeter System is a non-invasive medical device for measurement of venous blood oxygenation.</description>
    <arm_group_label>Heart Failure Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Avoximeter 4000</intervention_name>
    <description>The portable Avoximeter 4000 provides rapid, accurate assessment of the patient's true oxygenation status at the bedside. Features: Results in less than 10 seconds; No sample preparation required; Uses whole blood sample; Easy to use.</description>
    <arm_group_label>Heart Failure Patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Acute and chronic heart failure patients already receiving right heart catheterization&#xD;
        (RHC) as part of their usual care&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 and older&#xD;
&#xD;
          -  Heart failure patients already receiving RHC as part of their usual care&#xD;
&#xD;
          -  Signed written and informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lack of patient consent&#xD;
&#xD;
          -  Subject is pregnant&#xD;
&#xD;
          -  Evidence of abnormal neck anatomy&#xD;
&#xD;
          -  Subject does not have visible left and right jugular veins&#xD;
&#xD;
          -  Subject has occluded internal jugular veins under ultrasound imaging&#xD;
&#xD;
          -  Allergic to adhesive tape&#xD;
&#xD;
          -  Ongoing photodynamic therapy&#xD;
&#xD;
          -  Presence of known anatomical shunt or AV dialysis fistula&#xD;
&#xD;
          -  Known central vein stenosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd M Koelling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan Cardiovascular Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>July 18, 2013</study_first_submitted>
  <study_first_submitted_qc>July 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2013</study_first_posted>
  <last_update_submitted>September 25, 2015</last_update_submitted>
  <last_update_submitted_qc>September 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>venous oximeter</keyword>
  <keyword>non-invasive monitor</keyword>
  <keyword>heart failure (HF)</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

